Mortality in Parkinson's disease: A 20-year follow-up study
โ Scribed by Anja Diem-Zangerl; Klaus Seppi; Gregor K. Wenning; Eugen Trinka; Gerhard Ransmayr; Wilhelm Oberaigner; Werner Poewe
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 143 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
We determined mortality rates and predictors of survival in 238 consecutive patients with Parkinson's disease (PD) with symptom onset between 1974 and 1984. All patients were regularly followed at the Movement Disorder Clinic (Department of Neurology at the Innsbruck Medical University) until December 31, 2004, or death. As of December 31, 2004, 189 patients had died. Standardized mortality ratios (SMRs) increased over time. SMRs were 0.6 (95% CI 0.4โ1.0) by 5 years, 0.9 (95% CI 0.7โ1.2) by 10 years, 1.2 (95% CI 1.0โ1.4) by 15 years, and 1.3 (95% CI 1.1โ1.5) by 20 to 30 years. SMR for male patients was significantly increased to 1.3 (95% CI 1.1โ1.6), whereas SMR increase of 1.2 (0.9โ1.4) observed in female patients was not significant. Significantly increased SMRs were detected in patients with younger and older age of onset. Male gender, gait disorder, lack of tremor, and lack of asymmetry as presenting clinical features predicted poor survival in a Cox's proportional hazard analysis. This study demonstrates similar survival of patients with PD to the normal control population up to a disease duration of 10 years, followed by a modest rise of mortality with disease duration beyond 10 years compared with the general population. Under regular specialist care using all currently available therapies life expectancy in PD does not appear seriously compromised, but male gender, gait disorder, and absent rest tremor at presentation are associated with poorer longโterm survival. ยฉ 2009 Movement Disorder Society
๐ SIMILAR VOLUMES
## Abstract Parkinson's disease (PD) can be symptomatically controlled with standard treatments; however, after a few years, this response typically declines and most patients develop motor complications. We carried out a prospective practiceโbased study to evaluate the evolution appearance and evo
## Abstract Fatigue affects about 50% of Parkinson's disease (PD) patients and is frequently one of its most disabling aspects. It does not correlate with disease severity or duration but does correlate with depression. Fatigue and depression are distinct symptoms and fatigue often fails to respond
## Abstract To study prevalence of hallucinations in patients with Parkinson's disease (PD) during a 1โyear period, and identify factors predictive of the onset of hallucinations in patients who were hallucinationโfree at baseline, 141 unselected outpatients with PD were evaluated prospectively for